For the Inventor, By the Inventor

Enter assignee name

Zurich, Switzerland

University of Zürich

USPTO Granted Patents = 97

CIPO Patents = 10

EPO Patents = 43

Forward Citations = 508

Loading Chart...

Loading Chart...

191 inventors (with patents filed for the assignee):

Jan Grimm (24 out of 38 patents)

Roger Nitsch (23 out of 28 patents)

Christoph Hock (19 out of 20 patents)

4. Andreas Plückthun (8 out of 19 patents)

5. Fabio Montrasio (6 out of 10 patents)

6. Maria Grazia Barenco Montrasio (6 out of 6 patents)

7. Andreas Weihofen (6 out of 6 patents)

8. Christoph Esslinger (6 out of 7 patents)

9. Marlen Knobloch (6 out of 6 patents)

10. Paul H Weinreb (6 out of 17 patents)

11. Annemarie Honegger (5 out of 7 patents)

12. Kathrin Tissot (5 out of 11 patents)

13. Jean-Luc Baeriswyl (5 out of 5 patents)

14. Uwe Zangemeister-Wittke (5 out of 5 patents)

15. Claudio Di Paolo (5 out of 5 patents)

Core Competencies:

Neural Networks

Medical Imaging

Immunotoxins

Recombinant Antibodies

MicroRNA

Alzheimer's Disease

Cancer Treatment

Binding Molecules

Optical MRI

Multi-Strain Antibodies

Rheumatoid Arthritis

Surgical Devices

97 patents: Sort by Forward Citations

1. 12299576 - Neural network-based inference method and apparatus (2025-05-13),

2. 12282840 - Method and apparatus with neural network layer contraction (2025-04-21),

3. 12217417 - Learning-based domain transformation for medical images (2025-02-04),

4. 11971416 - Analysis apparatus (2024-04-30),

5. 11713352 - Immunotoxin for treating cancer (2023-08-01),

6. 11713351 - Immunotoxin for treating cancer (2023-08-01),

7. 11649455 - Micro RNA expression constructs and uses thereof (2023-05-16),

8. 11608372 - Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases (2023-03-21),

9. 11352441 - Human anti-SOD1 antibodies (2022-06-07),

10. 11091540 - TDP-43 specific binding molecules (2021-08-17),

11. 10870887 - Mutations in SPTLC2 gene associated with sensory neuropathy (2020-12-22),

12. 10858429 - Methods for treating cancer using an immunotoxin (2020-12-08),

13. 10703808 - Human anti-alpha-synuclein antibodies (2020-07-07),

14. 10544213 - Compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose tolerance (2020-01-28),

15. 10450365 - Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases (2019-10-22),

The University of Zürich (UZH) is a leading research university in Switzerland. Established in 1833, UZH offers a wide range of academic programs across various disciplines. With over 26,000 students and 4,600 employees, UZH is committed to providing high-quality education and conducting cutting-edge research at both national and international levels. The university is located in Zürich, a vibrant city known for its excellence in finance, technology, and innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

97 Patents

#13 in Zurich

#161 in Switzerland

#7,781 in the World

Zurich, Switzerland

University of Zürich

Forward Citations = 508

191 inventors:

Jan Grimm (24 out of 38 patents)

Roger Nitsch (23 out of 28 patents)

Christoph Hock (19 out of 20 patents)

4. Andreas Plückthun (8 out of 19 patents)

5. Fabio Montrasio (6 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…